Join
Live feed
·
PRReleasevia Quantisnow
DMK Pharmaceuticals Corporation logo

DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023

ByQuantisnow·Wall Street's wire, on your screen.
DMK· DMK Pharmaceuticals Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DMK (DMK Pharmaceuticals Corporation) and more on Quantisnow.